Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PF 05089771 (Alias: PF-05089771, PF05089771)

Catalog No. T7502L Copy Product Info
Purity: 99.42%
😃Good
PF 05089771 is a Selective inhibitor of Nav1.7 (IC50 = 11 nM) that interacts with the voltage-sensor domain of domain IV. It shows a slow onset of the block that is depolarization and concentration-dependent.

PF 05089771

Copy Product Info
😃Good
Catalog No. T7502L
Alias PF-05089771, PF05089771

PF 05089771 is a Selective inhibitor of Nav1.7 (IC50 = 11 nM) that interacts with the voltage-sensor domain of domain IV. It shows a slow onset of the block that is depolarization and concentration-dependent.

PF 05089771
Cas No. 1235403-62-9
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$62In StockIn Stock
5 mg$148In StockIn Stock
10 mg$196In StockIn Stock
25 mg$326In StockIn Stock
50 mgPreferentialIn StockIn Stock
1 mL x 10 mM (in DMSO)$167In StockIn Stock
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.42%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

PF 05089771 AI Summary
PF 05089771 exhibits potent bioactivity as an inhibitor of the NaV1.7 ion channel, with an IC50 of 11.0 nM in human NaV1.7 expressed in HEK293 cells and 8.0 nM in mouse Nav1.7 channels in an inactivated state. It also shows significant selectivity over other sodium channels, such as Nav1.5, and demonstrates a high plasma protein binding across multiple species: 99.76% in humans, 99.52% in dogs, 99.45% in rats, and 98.7% in mice. The compound has notable oral bioavailability, moderate volume of distribution, and relatively short half-life in rat and dog models. Pharmacokinetically, it has a log D value of 2.3, an acidic pKa of 6.2, intrinsic clearance of 5.62 µL.min-1.(10^6cells)-1 in human hepatocytes, and a clearance rate of 40.0 mL.min-1.kg-1. In terms of therapeutic potential, PF 05089771 shows analgesic effects, reducing formalin-induced paw flinching by 52.0% in Sprague-Dawley rats at 100 mg/kg. Additionally, it has moderate inhibitory activity against CYP2C9 (IC50 = 299.0 nM) and antiviral activity against SARS-CoV-2 with an IC50 greater than 20,000 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
PF 05089771 is a Selective inhibitor of Nav1.7 (IC50 = 11 nM) that interacts with the voltage-sensor domain of domain IV. It shows a slow onset of the block that is depolarization and concentration-dependent.
Targets&IC50
Nav1.7 (human):11 nM (IC50), Nav1.7 (mouse):8 nM (IC50), Nav1.7 (rat):171 nM (IC50), Nav1.7 (dog):13 nM (IC50), CynNav1.7:12 nM (IC50)
SynonymsPF-05089771, PF05089771
Chemical Properties
Molecular Weight500.35
FormulaC18H12Cl2FN5O3S2
Cas No.1235403-62-9
SmilesNc1n[nH]cc1-c1cc(Cl)ccc1Oc1cc(F)c(cc1Cl)S(=O)(=O)Nc1cscn1
Relative Density.1.673 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 30 mg/mL (59.96 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9986 mL9.9930 mL19.9860 mL99.9300 mL
5 mM0.3997 mL1.9986 mL3.9972 mL19.9860 mL
10 mM0.1999 mL0.9993 mL1.9986 mL9.9930 mL
20 mM0.0999 mL0.4997 mL0.9993 mL4.9965 mL
50 mM0.0400 mL0.1999 mL0.3997 mL1.9986 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PF 05089771 | purchase PF 05089771 | PF 05089771 cost | order PF 05089771 | PF 05089771 chemical structure | PF 05089771 formula | PF 05089771 molecular weight